PyInvesting

Market research

ERF.PA Eurofins Scientific SE

PA EUR Healthcare

Latest close

87.72 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
15B
P/E ratio
29.94
Analyst target
73.7214
Dividend yield
0.8%
Beta
0.81

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Eurofins Scientific SE is currently in a long term uptrend where the price is trading 29.0% above its 200 day moving average.

From a valuation standpoint, the stock is 98.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.0.

Eurofins Scientific SE's total revenue sank by 0.0% to $1B since the same quarter in the previous year.

Its net income has dropped by 0.0% to $68M since the same quarter in the previous year.

Finally, its free cash flow grew by 89.3% to $290M since the same quarter in the previous year.

Based on the above factors, Eurofins Scientific SE gets an overall score of 3/5.